Meet the DermaSensor Team

Operational Team

Cody Simmons

Chief Executive Officer

Cody is a bioengineer and entrepreneur that has focused all of his career on bringing new health technologies to physicians and patients. Most recently Cody led commercial efforts for a Silicon Valley medical device screening startup and held BD and commercial strategy roles at Genentech.

Ryan Freiden

Chief Operations Officer

Ryan Freiden

Chief Operations Officer

Ryan has over 16 years of experience founding and scaling companies in consumer goods, healthcare, and enterprise technologies. Recently, Ryan led the growth for a healthcare supply chain technology and previously ran the international manufacturing and distribution of consumer hardware electronics.

Larry Anderson

Chief Commercial Officer

Larry Anderson

Chief Commercial Officer

Larry is a West Point Graduate with 20 years of medical device experience, specializing in building teams and launching disruptive technologies. Most recently, Larry led the sales team at Acessa Health to a successful exit to Hologic during the covid-19 pandemic. His previous organizations include Ethicon Women’s Health and Urology, Interlace Medical, Hologic, and BG Medical.

Jacqueline Barberena

Senior Director of Marketing

Jacqueline Barberena

Senior Director of Marketing

Jacqueline has over a decade of medical device marketing experience with Abbott and STARLIMS, with expertise building and leading marketing teams focused on B2B marketing for similar primary care and diagnostic products that better equip HCPs for point-of-care testing and public health efforts.

Justin Frazier

Senior Director of Clinical Operations

Justin Frazier

Senior Director of Clinical Operations

Justin has been leading DermaSensor’s Clinical Operations group since 2017, responsible for executing the company’s pipeline of clinical studies. In his 17 years in Clinical Operations, Justin has worked with several medical device companies and CROs planning, implementing, and managing pre- and post-market medical device clinical studies. His previous employers include ReWalk Robotics, Smith & Nephew, Covidien/Medtronic, Massachusetts General Hospital, and PAREXEL.

Kiran Chatha, MD, MPH

Clinical and Medical Science Liaison

Kiran Chatha, MD, MPH

Clinical and Medical Science Liaison

Kiran has blended experience in clinical medicine and research in orthopedic surgery at the Cleveland Clinic with an expertise in study protocol design, statistics and data analysis through her MPH program. Most recently she worked in the medical device industry, specifically with regulatory writing for obtaining CE mark for surgical devices.

Robby Simons

Director of QA/RA

Robby Simons

Director of QA/RA

Robby is a seasoned professional with an impressive track record spanning more than two decades within the dynamic and highly regulated medical device industry. His extensive expertise encompasses a wide spectrum of roles and responsibilities, contributing significantly to the field of Quality and Regulatory affairs.

Kevin Scrimshaw

Commercial Director ANZ

Kevin Scrimshaw

Commercial Director ANZ

20+ years of healthcare industry experience in Business Development, Sales & Marketing Management, General Management and Director for companies such as HP, Agilent Technologies, Philips Healthcare, Mindray Medical, and Stanley Healthcare, Kevin has extensive experience working with healthcare providers across the Asia Pacific region.

Shannon Whiteley

Territory Business Manager – NSW/ACT

Shannon Whiteley

Territory Business Manager – NSW/ACT

20 years experience in the health care sector, working with companies such as MSD, National Home Doctor, and Mundipharma. She has been involved with many projects working to identify and reduce treatment gaps and achieve improved patient outcomes. She believes that optimal patient management should be the first priority.

Martina Clark

Territory Business Manager – VIC

Martina Clark

Territory Business Manager – VIC

17+ years of experience across multiple industries including pharmaceutical, healthcare, disability and aged care. She has a strong background in account management, BD, operations and entrepreneurship. She is passionate about social change, preventative health, and thinking outside the box to deliver solutions with long-term sustainable value.

Jeriah Hercules

Operations Associate

Jeriah Hercules

Operations Associate

Jeriah is a project manager and creative designer. Before joining DermaSensor, Jeriah received his undergraduate degree from University of Delaware and then moved to work as a UX/UI designer based in Philadelphia. Jeriah is passionate about creating user experiences and systems that promote positive impact.

Board of Directors

Cody Simmons

Chief Executive Officer

Cody Simmons

Chief Executive Officer

Maurice Ferre, MD

Chairman

Maurice Ferre, MD

Chairman

Dr. Ferre is also the current CEO of InSightec, the former CEO of MAKO Surgical and a former VP at GE Healthcare. He has had multiple successful medical device exits (MAKO sold to Stryker for ~$1.7B), three CE marks, and successfully commercialized two products.

Ivan Delevic

Director

Ivan Delevic

Director

CEO of OrthoSensor, Ivan is the former SVP of Sales, Marketing, and Business Development for MAKO Surgical, and a former GM at GE Healthcare. Ivan brings a wealth of domestic and international medical device industry experience from his prior leadership roles.

Christopher Dewey

Director

Christopher Dewey

Director

Founder and President of The Cannon Group Inc, aka, Cannon Films, the first independent film company, Christopher later became a partner at Bear, Stearns & Co. Inc. Christopher is a Founding board member of Mako Surgical, (MAKO) and an early investor in companies such as Magic Leap and Auris Surgical.

David Matlin

Director

David Matlin

Director

David Matlin is co-founder and Chief Executive Officer of MatlinPatterson and serves on the Boards of Directors of portfolio companies Flagstar Bank, CalAtlantic Group, Inc. and is also a director of Matlin & Partners Acquisition Corporation.

Scientific Advisory Board

Cristiane Benvenuto, MD

As CMO for DermaSensor and liaison for the SAB, Cristiane has extensive dermatology, digital health and business leadership experience. She completed both an MD and a PhD, co-founded two digital health companies, practiced as a Dermatologist for several years in Brazil, and was a Fellow at Memorial Sloan Kettering. She also holds an MBA from the Wharton School.

Irving Bigio, PhD

Professor of Biomedical Engineering at Boston University and one of the top spectroscopy researchers in the world, Dr. Bigio is the original inventor and patent holder for Elastic Scattering Spectroscopy. He has authored over 200 scientific publications on non-linear and biomedical optics with more than 30 on tissue dysplasia and malignancy characterization.

Holly Christman, MD

Holly has a passion for helping primary care providers learn Dermatology and has been teaching for 3 years at One Medical Group. An Assistant Clinical Professor of Dermatology at UCSF, where she completed medical school and her Dermatology training, including Mohs. Private practice in all aspects of Dermatology.

John Geisse, MD

President of Solano Dermatology Associates and Clinical Professor, Depts of Dermatology and Pathology at UCSF. Leader in Dermatologic and Mohs Micrographic Surgery, and boarded in Dermatopathology. Clinical Research background in basal cell carcinoma. Referral Practice in Dermatopathology and Mohs Micrographic Surgery and Reconstructive Surgery.

David Leffell, MD

Yale School of Medicine Professor of Dermatology & Surgery Chief, Dr. Leffell is the author of more than 150 publications including the popular book “Total Skin.“ He specializes in skin cancer and melanoma diagnosis and surgical treatment. The Cutaneous Oncology Unit that he founded in 1988 now performs specialized surgical treatment on more than 3,500 patients annually.

Giovanni Pellacani, MD

Professor and Chairman of the Department of Dermatology at University of Modena and Reggio Emilia in Italy. Research focus in the field of dermato-oncology, non-invasive diagnosis, cutaneous physiopathology and skin bioengineering. A leader and member of various European and international dermatology and dermatologic imaging societies.

Paul Salmon, FRACP

Dr Paul Salmon is a Dermatologist specialising in Dermatologic Surgery and Mohs facial skin cancer surgery in Tauranga and Auckland. He has over 20 years experience in Mohs, reconstructive, and cosmetic dermatologic surgery, with more than 50 published scientific papers on skin cancer.

Todd Thames, MD

A physician with Grand Rounds and holds a MS in Health Care Administration from Trinity University. He is a Fellow in the American Academy of Family Physicians. He speaks nationally on topics ranging from cardiovascular disease, to medical ethics, to health care economics and policy. Dr. Thames has >25 years of experience in medicine and the practice of health care administration.

Dr. Jane Grant-Kels

Dr. Jane Grant-Kels is Professor and founding Chair of the Department of Dermatology at the University of Connecticut (UCONN) Health Center and Medical School. She was the founding director of the dermatology residency program and founding director of the dermatopathology laboratory and the melanoma program.

Learn About Our Device

Explore

Our History

As two leading entrepreneurs and investors in health technology companies, Dr. Maurice Ferre (co-founder and chairman) and Christopher Dewey (co-founder) identified a fundamental issue with skin cancer screening and lack of access to care for individuals with skin lesions of concern. This was particularly apparent in primary care where early detection of skin cancer is often hampered by limited consultation time and limited dermatology training, leading to a lack of confidence in diagnosing skin cancer.

They founded DermaSensor in 2009 and started collaborating with Dr. Irving Bigio, Professor of Biomedical Engineering at Boston University and one of the top spectroscopy researching in the world. Dr. Bigio is the original inventory and patent holder for Elastic Scattering Spectroscopy (ESS), a key component of the DermaSensor Device.

Since the invention of ESS in 1994, there have been over 1,000 ESS publications and over 50 publications on ESS clinics studies. DermaSensor began ints own skin-specific studies using this technology in 2011 and began its first study on the commercial prototype of the device in 2017.

Meet the DermaSensor Team

Operational Team

Board of Directors

Scientific Advisory Board

Learn About Our Device

Our History

ABOUT US

PRODUCT

LEARN

CONNECT

BUY

Meet the DermaSensor Team

Operational Team

Board of Directors

Scientific Advisory Board

Learn About Our Device

Our History

Download the DermaSensor Brochure